Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects112
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker80
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review73
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”59
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors53
A Window of Opportunity for Newborn Screening48
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate47
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target42
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models39
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma39
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?32
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights31
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk31
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors29
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach27
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics26
Afamitresgene Autoleucel: First Approval26
Personalizing Oncolytic Immunovirotherapy Approaches25
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders25
Correction to: Revakinagene Taroretcel: First Approval25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease22
Advances and Challenges in the Diagnosis of Leishmaniasis21
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology20
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations20
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges20
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy19
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”18
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study18
Long-Range PCR and Nanopore Sequencing Enables High-Throughput Detection of TCF4 Trinucleotide Repeat Expansions in Fuchs Endothelial Corneal Dystrophy18
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review17
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy17
Molecular Therapeutics in Development to Treat Alzheimer’s Disease17
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer16
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants16
Smart PROTACs Enable Controllable Protein Degradation for Precision Cancer Therapy16
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer15
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies15
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort15
Achromatopsia: Genetics and Gene Therapy15
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia15
The Road Traveled and Journey Ahead for the Genetics and Genomics of Tinnitus15
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease14
Lifileucel: First Approval14
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis14
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?14
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis14
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation13
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders13
Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases13
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings12
The Role οf Ion Channels in the Development and Progression of Prostate Cancer12
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer12
Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer11
Correction to: Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus11
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”11
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma11
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting11
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models11
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma11
Emerging RNAi Therapies to Treat Hypertension11
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R11
Obecabtagene Autoleucel: First Approval10
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis10
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”10
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab10
Inner Ear Gene Therapy: An Overview from Bench to Bedside10
EasyNAT MP Assay: A Simple, Rapid, and Low-Cost Method to Detect Mycoplasma pneumoniae Using Cross-Priming Amplification Technology10
Future Prospects for Epigenetics in Autism Spectrum Disorder10
Blood Biomarkers of Long COVID: A Systematic Review10
Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features10
0.4417781829834